vs

Side-by-side financial comparison of COHEN & STEERS, INC. (CNS) and Ecovyst Inc. (ECVT). Click either name above to swap in a different company.

Ecovyst Inc. is the larger business by last-quarter revenue ($199.4M vs $143.8M, roughly 1.4× COHEN & STEERS, INC.). On growth, Ecovyst Inc. posted the faster year-over-year revenue change (34.0% vs 2.9%). Ecovyst Inc. produced more free cash flow last quarter ($22.9M vs $-126.4M). Over the past eight quarters, Ecovyst Inc.'s revenue compounded faster (18.7% CAGR vs 8.3%).

Cohen & Steers is an American investment management company. It focuses on investments in real estate securities via real estate investment trusts (REIT) and alternative income via preferred securities.

Ecovyst Inc. is a global sustainable specialty materials provider that develops and manufactures high-performance catalysts and functional additives. Its offerings serve key segments including industrial manufacturing, consumer goods, and environmental protection, helping clients improve operational efficiency and lower carbon emissions across North America, Europe, and Asia-Pacific markets.

CNS vs ECVT — Head-to-Head

Bigger by revenue
ECVT
ECVT
1.4× larger
ECVT
$199.4M
$143.8M
CNS
Growing faster (revenue YoY)
ECVT
ECVT
+31.1% gap
ECVT
34.0%
2.9%
CNS
More free cash flow
ECVT
ECVT
$149.4M more FCF
ECVT
$22.9M
$-126.4M
CNS
Faster 2-yr revenue CAGR
ECVT
ECVT
Annualised
ECVT
18.7%
8.3%
CNS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CNS
CNS
ECVT
ECVT
Revenue
$143.8M
$199.4M
Net Profit
$34.9M
Gross Margin
23.4%
Operating Margin
28.0%
10.9%
Net Margin
24.3%
Revenue YoY
2.9%
34.0%
Net Profit YoY
-23.9%
EPS (diluted)
$0.67
$0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CNS
CNS
ECVT
ECVT
Q4 25
$143.8M
$199.4M
Q3 25
$141.7M
$204.9M
Q2 25
$136.1M
$176.1M
Q1 25
$134.5M
$143.1M
Q4 24
$139.8M
$148.9M
Q3 24
$133.2M
$153.9M
Q2 24
$121.7M
$154.0M
Q1 24
$122.7M
$141.6M
Net Profit
CNS
CNS
ECVT
ECVT
Q4 25
$34.9M
Q3 25
$41.7M
$-79.3M
Q2 25
$36.8M
$6.0M
Q1 25
$39.8M
$-3.6M
Q4 24
$45.8M
Q3 24
$39.7M
$14.3M
Q2 24
$31.8M
$8.3M
Q1 24
$34.0M
$1.2M
Gross Margin
CNS
CNS
ECVT
ECVT
Q4 25
23.4%
Q3 25
25.4%
Q2 25
22.8%
Q1 25
13.3%
Q4 24
28.9%
Q3 24
29.3%
Q2 24
27.3%
Q1 24
23.5%
Operating Margin
CNS
CNS
ECVT
ECVT
Q4 25
28.0%
10.9%
Q3 25
34.5%
13.8%
Q2 25
31.8%
9.0%
Q1 25
33.6%
-0.7%
Q4 24
35.3%
15.1%
Q3 24
33.7%
17.9%
Q2 24
31.5%
14.1%
Q1 24
32.8%
9.5%
Net Margin
CNS
CNS
ECVT
ECVT
Q4 25
24.3%
Q3 25
29.4%
-38.7%
Q2 25
27.1%
3.4%
Q1 25
29.6%
-2.5%
Q4 24
32.8%
Q3 24
29.8%
9.3%
Q2 24
26.1%
5.4%
Q1 24
27.7%
0.9%
EPS (diluted)
CNS
CNS
ECVT
ECVT
Q4 25
$0.67
$0.06
Q3 25
$0.81
$-0.69
Q2 25
$0.72
$0.05
Q1 25
$0.77
$-0.03
Q4 24
$0.89
$-0.26
Q3 24
$0.77
$0.12
Q2 24
$0.63
$0.07
Q1 24
$0.68
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CNS
CNS
ECVT
ECVT
Cash + ST InvestmentsLiquidity on hand
$145.5M
$197.2M
Total DebtLower is stronger
$392.6M
Stockholders' EquityBook value
$562.0M
$603.4M
Total Assets
$876.7M
$1.3B
Debt / EquityLower = less leverage
0.65×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CNS
CNS
ECVT
ECVT
Q4 25
$145.5M
$197.2M
Q3 25
$98.1M
$82.0M
Q2 25
$95.4M
$69.6M
Q1 25
$65.2M
$127.5M
Q4 24
$183.0M
$131.4M
Q3 24
$106.5M
$123.5M
Q2 24
$122.0M
$83.3M
Q1 24
$99.5M
$103.1M
Total Debt
CNS
CNS
ECVT
ECVT
Q4 25
$392.6M
Q3 25
$854.8M
Q2 25
$856.6M
Q1 25
$859.0M
Q4 24
$860.8M
Q3 24
$862.7M
Q2 24
$862.4M
Q1 24
$866.2M
Stockholders' Equity
CNS
CNS
ECVT
ECVT
Q4 25
$562.0M
$603.4M
Q3 25
$550.3M
$607.9M
Q2 25
$528.5M
$692.4M
Q1 25
$507.7M
$698.7M
Q4 24
$511.7M
$700.5M
Q3 24
$491.0M
$729.4M
Q2 24
$463.2M
$717.3M
Q1 24
$378.9M
$711.4M
Total Assets
CNS
CNS
ECVT
ECVT
Q4 25
$876.7M
$1.3B
Q3 25
$801.6M
$1.7B
Q2 25
$751.0M
$1.8B
Q1 25
$834.9M
$1.8B
Q4 24
$812.4M
$1.8B
Q3 24
$727.8M
$1.8B
Q2 24
$784.1M
$1.8B
Q1 24
$680.7M
$1.8B
Debt / Equity
CNS
CNS
ECVT
ECVT
Q4 25
0.65×
Q3 25
1.41×
Q2 25
1.24×
Q1 25
1.23×
Q4 24
1.23×
Q3 24
1.18×
Q2 24
1.20×
Q1 24
1.22×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CNS
CNS
ECVT
ECVT
Operating Cash FlowLast quarter
$-120.4M
$41.8M
Free Cash FlowOCF − Capex
$-126.4M
$22.9M
FCF MarginFCF / Revenue
-87.9%
11.5%
Capex IntensityCapex / Revenue
4.2%
9.4%
Cash ConversionOCF / Net Profit
-3.45×
TTM Free Cash FlowTrailing 4 quarters
$-253.6M
$69.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CNS
CNS
ECVT
ECVT
Q4 25
$-120.4M
$41.8M
Q3 25
$55.1M
$55.3M
Q2 25
$-67.6M
$33.0M
Q1 25
$-108.9M
$10.3M
Q4 24
$96.7M
$43.5M
Q3 24
$25.6M
$59.9M
Q2 24
$31.4M
$10.0M
Q1 24
$4.9M
$36.5M
Free Cash Flow
CNS
CNS
ECVT
ECVT
Q4 25
$-126.4M
$22.9M
Q3 25
$52.6M
$53.2M
Q2 25
$-69.8M
$7.8M
Q1 25
$-110.0M
$-14.0M
Q4 24
$85.0M
$30.9M
Q3 24
$24.2M
$53.6M
Q2 24
$27.1M
$-9.3M
Q1 24
$537.0K
$19.1M
FCF Margin
CNS
CNS
ECVT
ECVT
Q4 25
-87.9%
11.5%
Q3 25
37.1%
26.0%
Q2 25
-51.3%
4.4%
Q1 25
-81.8%
-9.8%
Q4 24
60.8%
20.7%
Q3 24
18.2%
34.9%
Q2 24
22.3%
-6.1%
Q1 24
0.4%
13.5%
Capex Intensity
CNS
CNS
ECVT
ECVT
Q4 25
4.2%
9.4%
Q3 25
1.8%
1.0%
Q2 25
1.6%
14.4%
Q1 25
0.8%
16.9%
Q4 24
8.3%
8.5%
Q3 24
1.1%
4.1%
Q2 24
3.5%
12.5%
Q1 24
3.5%
12.3%
Cash Conversion
CNS
CNS
ECVT
ECVT
Q4 25
-3.45×
Q3 25
1.32×
Q2 25
-1.84×
5.52×
Q1 25
-2.74×
Q4 24
2.11×
Q3 24
0.65×
4.21×
Q2 24
0.99×
1.20×
Q1 24
0.14×
29.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CNS
CNS

Segment breakdown not available.

ECVT
ECVT

Industrial Mining Automotive$101.3M51%
Regeneration And Treatment Services$90.0M45%
Other$8.1M4%

Related Comparisons